UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

Frontiers in endocrinology (Lausanne), 2013, Vol.3, p.184

2013

Volltextzugriff (PDF)

Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians

Oncotarget, 2017-08, Vol.8 (31), p.50792-50803

2017

Volltextzugriff (PDF)

Real-life efficacy and safety of nivolumab for non-small cell lung cancer: A 10-months French cohort

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20633-e20633

2016

Volltextzugriff (PDF)

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

Biotechnology research international, 2016, Vol.2016, p.1-7

2016

Volltextzugriff (PDF)

2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group

Annals of oncology, 2009-09, Vol.20 (9), p.1459-1471

2009

Volltextzugriff (PDF)

Long-term results of endobronchial brachytherapy: A curative treatment?

International journal of radiation oncology, biology, physics, 2007-02, Vol.67 (2), p.425-430

2007

Volltextzugriff (PDF)

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

Clinical medicine insights. Therapeutics, 2010-01, Vol.2, p.179

2010

Volltextzugriff (PDF)

Association between lung cancer somatic mutations and occupational exposure in never-smokers

The European respiratory journal, 2017-10, Vol.50 (4), p.1700716-1700716

2017

Volltextzugriff (PDF)

Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20543-e20543

2017

Volltextzugriff (PDF)

No impact of passive smoke on the somatic profile of lung cancers in never-smokers

The European respiratory journal, 2015-05, Vol.45 (5), p.1415-1425

2015

Volltextzugriff (PDF)

Use of Adjuvant Chemotherapy in Non-small Cell Lung Cancer in Routine Practice

Journal of thoracic oncology, 2009-12, Vol.4 (12), p.1504-1510

2009

Volltextzugriff (PDF)

Abstract 2231: The prevalence of EGFR and KRAS mutations in a population of African immigrants in France is closer to that of Asian populations than to white Europeans

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2231-2231

2014

Volltextzugriff (PDF)

Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts

ESMO open, 2024-06, Vol.9 (6), p.103594, Article 103594

2024

Volltextzugriff (PDF)

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1182-S1183

2017

Volltextzugriff (PDF)

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial: Topic: Miscellaneous

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1182-S1183

2017

Volltextzugriff (PDF)

Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7511-7511

2014

Volltextzugriff (PDF)

Adenocarcinoma of the Lung in down Syndrome: First Clinical Report

Tumori, 2013-07, Vol.99 (4), p.169-171

2013

Volltextzugriff (PDF)

Risk of Childhood Cancer and Adult Lung Cancer after Childhood Exposure to Passive Smoke: A Meta-Analysis

Environmental health perspectives, 2000-01, Vol.108 (1), p.73-82

2000

Volltextzugriff (PDF)

Serum p53 antibodies as early markers of lung cancer

Nature medicine, 1995-07, Vol.1 (7), p.701-702

1995

Volltextzugriff (PDF)

Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS7111-TPS7111

2012

Volltextzugriff (PDF)

Adenocarcinoma of the lung in Down syndrome: first clinical report

Tumori, 2013-07, Vol.99 (4), p.e169-e171

2013

Volltextzugriff (PDF)

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

The Lancet regional health. Europe, 2022-11, Vol.22, p.100492-100492, Article 100492

2022

Volltextzugriff (PDF)

0186 Women epidemiology lung cancer (welca) study: reproductive, hormonal, occupational risk factors and biobank

Occupational and environmental medicine (London, England), 2017-08, Vol.74 (Suppl 1), p.A56

2017

Volltextzugriff (PDF)

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

Clinical Medicine Insights: Therapeutics, 2010-01, Vol.2010 (2), p.CMT.S4510

2010

Volltextzugriff (PDF)

Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: Systematic review and meta-analysis of literature

Journal de médecine vasculaire, 2021-04, Vol.46 (2), p.53-65

2021

Volltextzugriff (PDF)

26 – 50 von 57

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBulletin Du Cancer

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(57)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians

Real-life efficacy and safety of nivolumab for non-small cell lung cancer: A 10-months French cohort

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group

Long-term results of endobronchial brachytherapy: A curative treatment?

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

Association between lung cancer somatic mutations and occupational exposure in never-smokers

Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression

No impact of passive smoke on the somatic profile of lung cancers in never-smokers

Use of Adjuvant Chemotherapy in Non-small Cell Lung Cancer in Routine Practice

Abstract 2231: The prevalence of EGFR and KRAS mutations in a population of African immigrants in France is closer to that of Asian populations than to white Europeans

Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial: Topic: Miscellaneous

Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial

Adenocarcinoma of the Lung in down Syndrome: First Clinical Report

Risk of Childhood Cancer and Adult Lung Cancer after Childhood Exposure to Passive Smoke: A Meta-Analysis

Serum p53 antibodies as early markers of lung cancer

Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302)

Adenocarcinoma of the lung in Down syndrome: first clinical report

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

0186 Women epidemiology lung cancer (welca) study: reproductive, hormonal, occupational risk factors and biobank

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: Systematic review and meta-analysis of literature

Aktive Filter

Suchergebnisse filtern